Immunohistochemical characterization of neuroendocrine cells in prostate cancer.
about
Androgen-targeted therapy-induced epithelial mesenchymal plasticity and neuroendocrine transdifferentiation in prostate cancer: an opportunity for interventionThe E3 ubiquitin ligase Siah2 contributes to castration-resistant prostate cancer by regulation of androgen receptor transcriptional activityNeuroendocrine differentiation in prostate cancerPrognostic role of neuroendocrine differentiation in prostate cancer, putting together the pieces of the puzzle.Oct4A is expressed by a subpopulation of prostate neuroendocrine cells.The molecular basis for ethnic variation and histological subtype differences in prostate cancer.Molecular pathology of prostate cancer revealed by next-generation sequencing: opportunities for genome-based personalized therapy.Primitive origins of prostate cancer: in vivo evidence for prostate-regenerating cells and prostate cancer-initiating cellsFrequent discordance between ERG gene rearrangement and ERG protein expression in a rapid autopsy cohort of patients with lethal, metastatic, castration-resistant prostate cancer.Hedgehog overexpression leads to the formation of prostate cancer stem cells with metastatic property irrespective of androgen receptor expression in the mouse modelProstate cancer and neuroendocrine differentiation: more neuronal, less endocrine?Origin of androgen-insensitive poorly differentiated tumors in the transgenic adenocarcinoma of mouse prostate model.PC3 is a cell line characteristic of prostatic small cell carcinoma.Pathogenesis of prostatic small cell carcinoma involves the inactivation of the P53 pathway.Growth and Progression of TRAMP Prostate Tumors in Relationship to Diet and ObesityPresence of antigen-specific somatic allelic mutations and splice variants do not predict for immunological response to genetic vaccination.Adaptation or selection--mechanisms of castration-resistant prostate cancer.Androgen-deprivation therapy-induced aggressive prostate cancer with neuroendocrine differentiation.Neuroendocrine differentiation of prostate cancer: a review.Strategies to avoid treatment-induced lineage crisis in advanced prostate cancer.Neuroendocrine differentiation of prostate cancer.FDG PET-CT demonstration of metastatic neuroendocrine tumor of prostate.Paneth cell-like change in benign prostate can account for P504S (AMACR) reactivity.Neuroendocrine tumors of the prostate.Androgen receptor signaling regulates T-type Ca2+ channel expression and neuroendocrine differentiation in prostate cancer cells.A Testosterone Metabolite 19-Hydroxyandrostenedione Induces Neuroendocrine Trans-Differentiation of Prostate Cancer Cells via an Ectopic Olfactory Receptor.GABA promotes gastrin-releasing peptide secretion in NE/NE-like cells: Contribution to prostate cancer progression.
P2860
Q21129293-C36E6604-0763-4EC0-8EB2-AD53C3BD31DFQ24337119-64B75476-1DD4-4DFC-8D9C-00477D533BB7Q24657547-0DA1B11D-9C96-4DC8-B0E8-11FEC92F5324Q33356928-8753E2D5-774D-408B-A91C-6A96CEFCCBF9Q33832001-C5A8F894-F6B7-4261-8CDD-937D0B0F7A6CQ33835864-B88A4D2C-43B3-4A99-862B-8276CFA3E9ACQ33862462-D3AD4B19-9E63-45A4-8A64-F48C90BFDFE2Q34126555-E037FCB0-6B99-4308-B36C-2D9A8FDEDAB9Q34143112-33746B47-AB86-42AA-93B6-8CEE3A6E838EQ34515977-4AA495C8-2968-4A08-B607-C68A79AC3430Q35141115-CEC83400-21AB-4ADA-9588-964036BA578AQ36143611-8F3A2551-CCFF-4F12-9C5B-9ABE4A8B276FQ36185201-D40319AD-DBBC-4FED-B113-1BA25EA032BEQ36206304-C4E79751-0BD4-4316-8AD9-AF1D566F276AQ36469104-4960CD61-C734-4B61-B7F6-45490482B1D6Q37703163-255D3804-F477-4270-8A4F-E32A729BDE3AQ38068116-EA14D5D4-9DF1-4E31-B4A3-385632894A73Q38192816-04410DD1-BFBB-42BA-B729-A9B9952DA902Q38326554-0C38707F-77C6-4F88-B276-9F779AB29BFCQ39016544-B1AFE25B-4E69-4F29-BA7B-2FD55C4C1C9DQ39179651-638BD4B1-C04A-4BFD-8A7C-EA91ED95EEBDQ39591941-44A06E40-51EB-4063-8E86-8E78CF297576Q42462247-8C0F77EE-99C1-453B-83CB-5BBBEBF2D867Q49347811-AF38CDA3-73A8-406A-9C49-D143903C25C6Q53686355-A2ED02B6-5AF3-491D-8963-FD25F7CA158EQ55285562-C83256E3-2C3B-4E51-803D-A896AE371AC7Q55606621-A734E8A0-8DD4-40A0-8396-A8B8581630F8
P2860
Immunohistochemical characterization of neuroendocrine cells in prostate cancer.
description
2006 nî lūn-bûn
@nan
2006 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Immunohistochemical characterization of neuroendocrine cells in prostate cancer.
@ast
Immunohistochemical characterization of neuroendocrine cells in prostate cancer.
@en
Immunohistochemical characterization of neuroendocrine cells in prostate cancer.
@nl
type
label
Immunohistochemical characterization of neuroendocrine cells in prostate cancer.
@ast
Immunohistochemical characterization of neuroendocrine cells in prostate cancer.
@en
Immunohistochemical characterization of neuroendocrine cells in prostate cancer.
@nl
prefLabel
Immunohistochemical characterization of neuroendocrine cells in prostate cancer.
@ast
Immunohistochemical characterization of neuroendocrine cells in prostate cancer.
@en
Immunohistochemical characterization of neuroendocrine cells in prostate cancer.
@nl
P2093
P356
P1433
P1476
Immunohistochemical characterization of neuroendocrine cells in prostate cancer.
@en
P2093
Jiaoti Huang
Jorge L Yao
P Anthony di Sant'Agnese
Patricia A Bourne
P2860
P304
P356
10.1002/PROS.20434
P577
2006-09-01T00:00:00Z